Key points are not available for this paper at this time.
Irritable bowel syndrome is associated with substantial costs to patients, healthcare systems and society. Considerable benefit could be obtained from effective interventions.
Canavan et al. (Tue,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: